R
Rhythm Pharmaceuticals, Inc. (RYTM)
NGM – Real vaqt narxi. Valyuta: USD
75.82
-6.08 (-7.42%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
75.84
+0.02 (0.02%)
Bozordan keyin: Mar 27, 2026, 7:15 PM EDT

NGM – Real vaqt narxi. Valyuta: USD
75.82
-6.08 (-7.42%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
75.84
+0.02 (0.02%)
Bozordan keyin: Mar 27, 2026, 7:15 PM EDT
This stock has a consensus price target of $127.69 based on the ratings of 16 analysts. The high is $157.00 and the low is $65.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 65 | $ 127.69 | $ 157 |
| O’zgarish | -14.27% | 68.41% | 107.07% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-23 | 38.49% | HC Wainwright & Co. | $100 → $105 | Maintains | Buy |
| 2026-03-20 | 87.29% | Citigroup | $131 → $142 | Maintains | Buy |
| 2026-03-20 | 96.52% | B of A Securities | $139 → $149 | Maintains | Buy |
| 2026-03-20 | 104.43% | Citizens | $152 → $155 | Maintains | Market Outperform |
| 2026-03-18 | 31.89% | HC Wainwright & Co. | $110 → $100 | Maintains | Buy |